© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Experts in the management of migraine discuss the prevalence of individuals taking acute migraine therapy and enumerate the various classes of agents available.
A discussion on the differences between acute and preventive migraine treatment, and the impact of treatment on quality of life.
June 17th 2021, 7:55pm
Some demographic groups face more limitations than others when seeking and receiving appropriate care for their headache disorders due to treatment disparities.
June 14th 2021, 3:15pm
Study results show that those with migraine are more likely to develop rheumatoid arthritis (RA) and those with RA are also more likely to have migraine.
June 9th 2021, 7:40pm
Survey results illustrate the detrimental effects of migraine on daily life.
June 7th 2021, 3:15pm
Almost half of US migraineurs hesitate to seek out care for their condition, according to research presented at the American Headache Society's 63rd Annual Scientific Meeting.
June 5th 2021, 11:00am
Results of an observational study indicate low estradiol levels could worsen vestibular migraine in postmenopausal women.
June 2nd 2021, 7:11pm
Findings from an observational study indicate that chronic migraineurs with medication overuse headache may be deficient in vitamin D.
May 26th 2021, 12:00pm
Analyses showed differential brain activity among migraineurs with anxiety compared with those without anxiety and healthy controls.
May 24th 2021, 12:00pm
Results from a genome-wide association study indicate blood clot factors may contribute to the cause of migraine with aura.
May 20th 2021, 2:00pm
Results of a US claims database show erenumab is associated with reduced acute medication use and health care resource utilization.
May 17th 2021, 4:17pm
Real-world data collected from 5 US health centers highlight erenumab's efficacy in chronic migraineurs.